The CPS-3 cohort was designed to help us understand the differences between people who get cancer and people who don’t get cancer. It incorporates modern technologies to address new and emerging cancer risk, prevention and survivorship questions.
We will follow this cohort for many years to see how changes in health, lifestyle, and enviornmental information are related to the risk of cancer, other diseases, or mortality.
Over 300,000 cancer-free participants from all 50 states, the District of Columbia, and Puerto Rico enrolled in CPS-3. Lifestyle, demographic and environmental survey data was collected and 99% of participants provided blood samples.
Tumor tissue is collected from medical providers of consenting participants who report a blood, breast, colorectal, ovarian, or prostate cancer diagnosis
Tumor tissue collection continues for consenting participants who report a blood, breast, colorectal, ovarian, or prostate cancer diagnosis
Tumor tissue collection continues for consenting participants who report a blood, breast, colorectal, ovarian, or prostate cancer diagnosis
Uses activity monitors to collect biometric data on physical activity and sedentary time
A secure, web-based portal used by participants to complete surveys, update information like cancer diagnoses or other health conditions, join sub-studies, and learn about our research
First launched as the Gut Microbiome Sub-study, this study will collect paired stool and saliva samples to enable research on the gut and oral microbiomes
Continued engagement with our dedicated participants along with the hard work of our research team will allow us to continue to collect data and conduct sub-studies for many decades into the futures.